.
MergerLinks Header Logo

New Deal


Announced

Completed

Farallon Capital and Marshall Wace led a $102m Series D funding round in InBrace.

Financials

Edit Data
Transaction Value£74m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

medical equipment

Medical Equipment

Completed

Venture Capital

United States

Private

Acquisition

Minority

orthodontics

Private Equity

Cross Border

Friendly

Synopsis

Edit

Farallon Capital, an investment management firm, and Marshall Wace, a hedge fund, led a $102m Series D funding round in InBrace, an orthodontic company. Additional Investors include BlackRock, Endeavour Vision, MVM Partners, RTW Investments, Soleus Capital, Vivo Capital, Novo Ventures and venBio. "The Series D funding further validates the ability of InBrace to attract new consumers who previously opted out of orthodontic treatment because they didn't have an option that fit their lifestyle. As a company founded by orthodontists, we developed InBrace to help orthodontists elevate the teeth straightening experience," John Pham, InBrace CEO and Co-Founder.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US